These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3321820)

  • 21. Intravenous methylprednisolone in the treatment of Graves' ophthalmopathy.
    Kendall-Taylor P; Crombie AL; Stephenson AM; Hardwick M; Hall K
    BMJ; 1988 Dec; 297(6663):1574-8. PubMed ID: 2906260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose intravenous corticosteroid therapy for Graves' ophthalmopathy.
    Macchia PE; Bagattini M; Lupoli G; Vitale M; Vitale G; Fenzi G
    J Endocrinol Invest; 2001 Mar; 24(3):152-8. PubMed ID: 11314743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response to tocilizumab treatment in Graves' ophthalmopathy by measuring rectus muscle thickness and chemosis using optical coherence tomography.
    de-Pablo-Gómez-de-Liaño L; Fernández-Vigo JI; Troyano-Rivas J; Niño-Rueda C; Romo-López Á; Gómez-de-Liaño R
    Arch Soc Esp Oftalmol (Engl Ed); 2018 Aug; 93(8):386-391. PubMed ID: 29937157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes of orbital tissue volumes and proptosis in patients with thyroid extraocular muscle swelling after methylprednisolone pulse therapy.
    Higashiyama T; Nishida Y; Ohji M
    Jpn J Ophthalmol; 2015 Nov; 59(6):430-5. PubMed ID: 26321629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of combined orbital radiation and systemic steroids in the management of Graves' orbitopathy.
    Kim JW; Han SH; Son BJ; Rim TH; Keum KC; Yoon JS
    Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):991-8. PubMed ID: 26876240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High dose intravenous methylprednisolone pulse therapy versus oral prednisone for thyroid-associated ophthalmopathy.
    Kauppinen-Mäkelin R; Karma A; Leinonen E; Löyttyniemi E; Salonen O; Sane T; Setälä K; Viikari J; Heufelder A; Välimäki M
    Acta Ophthalmol Scand; 2002 Jun; 80(3):316-21. PubMed ID: 12059873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of digital infrared thermal imaging in determining inflammatory state and follow-up effect of methylprednisolone pulse therapy in patients with Graves' ophthalmopathy.
    Chang TC; Hsiao YL; Liao SL
    Graefes Arch Clin Exp Ophthalmol; 2008 Jan; 246(1):45-9. PubMed ID: 17653750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative computed tomography of Graves' ophthalmopathy. Extraocular muscle and orbital fat in development of optic neuropathy.
    Feldon SE; Lee CP; Muramatsu SK; Weiner JM
    Arch Ophthalmol; 1985 Feb; 103(2):213-5. PubMed ID: 3838463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Success Treatment of Severe and Active Graves' Orbitopathy with Tocilizumab After Thyroidectomy and Maximum Dose of Intravenous Methylprednisolone.
    Pramono LA
    Acta Med Indones; 2023 Oct; 55(4):475-477. PubMed ID: 38213047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of real-time orbital ultrasound in Graves' ophthalmopathy: a comparison with computed tomography.
    Given-Wilson R; Pope RM; Michell MJ; Cannon R; McGregor AM
    Br J Radiol; 1989 Aug; 62(740):705-9. PubMed ID: 2670033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study.
    Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Lepri A; Pinchera A
    J Endocrinol Invest; 1991 Nov; 14(10):853-60. PubMed ID: 1802923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analysis of methylprednisolone pulse therapy for Graves' ophthalmopathy.
    Gao G; Dai J; Qian Y; Ma F
    Clin Exp Ophthalmol; 2014 Nov; 42(8):769-77. PubMed ID: 24617953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood Pressure Profile and N-Terminal-proBNP Dynamics in Response to Intravenous Methylprednisolone Pulse Therapy of Severe Graves' Orbitopathy.
    Miskiewicz P; Milczarek-Banach J; Bednarczuk T; Opolski G; Glowczynska R
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30261581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative CT of the orbit in Graves' disease.
    Ozgen A; Alp MN; Ariyürek M; Tütüncü NB; Can I; Günalp I
    Br J Radiol; 1999 Aug; 72(860):757-62. PubMed ID: 10624341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous cyclophosphamide pulse therapy is effective for refractory Graves' ophthalmopathy.
    Tanikawa T; Okada Y; Tanaka Y
    J UOEH; 2006 Jun; 28(2):185-91. PubMed ID: 16780226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Injection of methylprednisolone directly into the extraocular muscles of eyes with disturbed motility secondary to Graves' ophthalmopathy. Preliminary report].
    Mikita A; Mariak Z; Myśliwiec J
    Endokrynol Pol; 2005; 56(2):168-73. PubMed ID: 16335685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypokalemic paralysis following administration of intravenous methylprednisolone in a patient with Graves' thyrotoxicosis and ophthalmopathy.
    Tigas S; Papachilleos P; Ligkros N; Andrikoula M; Tsatsoulis A
    Hormones (Athens); 2011; 10(4):313-6. PubMed ID: 22281888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate-to-severe Graves' ophthalmopathy: a preliminary study.
    Ng CM; Yuen HK; Choi KL; Chan MK; Yuen KT; Ng YW; Tiu SC
    Hong Kong Med J; 2005 Oct; 11(5):322-30. PubMed ID: 16219950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum concentrations of HGF and IL-8 in patients with active Graves' orbitopathy before and after methylprednisolone therapy.
    Nowak M; Siemińska L; Karpe J; Marek B; Kos-Kudła B; Kajdaniuk D
    J Endocrinol Invest; 2016 Jan; 39(1):63-72. PubMed ID: 26062519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful treatment of hypothyroid Graves' disease with a combination of levothyroxine replacement, intravenous high-dose steroid and irradiation to the orbit.
    Koshiyama H; Mori S; Fujiwara K; Hayakawa K; Koh T
    Intern Med; 1993 May; 32(5):421-3. PubMed ID: 8400507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.